Bullish Analyst Sentiment on Salesforce (CRM) Amid Expanding Enterprise Demand and Strong Q3 Results

Salesforce, Inc. (NYSE:CRM) is one of the 15 best AI stocks to watch in December 2025.

As of December 8, 2025, roughly 80% of analysts remain bullish on Salesforce, Inc. (NYSE:CRM) with a median price target of $327.50. The consensus price target implies 26.19% upside.

Earlier, on December 5, 2025, The Fly reported that RBC Capital reiterated its “Sector Perform” rating on Salesforce, Inc. (NYSE:CRM) with a $250 price target. The update came following the company’s quarterly Customer Momentum & Success virtual update. The investment firm highlighted the company’s strong execution, growing momentum in AI-driven workflows, and rising adoption of its agentic enterprise framework. The collaborative ecosystem has already boosted bookings and net-new ARR. The firm expects a modest short-term financial impact of AI, but it believes the company is well-positioned to capture expanding enterprise demand for intelligence automation.

Meanwhile, on December 3, 2025, Salesforce, Inc. (NYSE:CRM) reported its fiscal Q3 2026 results. The quarter saw a 9% YoY revenue increase to $10.3 billion, meeting analyst expectations. Operating cash flow rose by 17% YoY to $2.3 billion, with free cash flow increasing 22% YoY to $2.2 billion. The strong top-line growth was driven by strength in the Agentforce and Data Cloud (Data 360) portfolios, where ARR surged 114%. This reflects the company’s strong momentum across its AI-focused product suite.

The strong quarterly performance also drew the attention of CMB International’s Saiyi He, who reiterated a “Buy” rating on Salesforce, Inc. (NYSE:CRM) with a $392 target. The analyst’s bullish stance stemmed from the company’s expanding product breadth, operating leverage, and confidence in its long-term financial trajectory.

Leveraging its secure platform that drives automation, intelligence, and growth, Salesforce, Inc. (NYSE:CRM) enables organizations to operate as agentic enterprises, unifying humans, AI agents, apps, and data.

While we acknowledge the potential of CRM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Small-Cap Biotech Stocks to Buy According to Analysts and 11 Overlooked Tech Stocks to Invest In.

Disclosure: None.